Please wait while we open this resource.
K
Guidelines & protocols
DAPAGLIFLOZIN FOR TREATING CHRONIC KIDNEY DISEASE
National Institute for Health and Care Excellence (NICE)
PDF202510 pages79 KB
The guidance outlines the criteria under which dapagliflozin should be funded as an add-on treatment to optimized standard care for patients with CKD. It emphasizes the importance of considering individual patient needs and the responsibilities of healthcare professionals in applying these recommendations. The document also discusses the evaluation process and the roles of the NICE committee members involved in the appraisal.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
Integrated CKD Management Guidelines for Uganda
Same clinical topic · Nephrology
KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR DIABETES AND CHAPTER 1, CHAPTER 2, & CHAPTER 4 UPDATE DRAFT
Same clinical topic · Nephrology
KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
KDIGO-2024-CKD-Guideline
Same clinical topic · Nephrology
DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE: SYNOPSIS OF THE KDIGO 2022 CLINICAL PRACTICE GUIDELINE UPDATE
Same clinical topic · Nephrology
KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Same clinical topic · Nephrology
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Same clinical topic · Nephrology